These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 10418046

  • 1. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P, Brion JP, Lebeau B, Grillot R, Ambroise-Thomas P.
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

  • 3. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP, Boutoille D, Tattevin P, Dargère S, Weinbreck P, Ansart S, Chennebault JM, Hutin P, Léautez-Nainville S, Gay-Andrieu F, Raffi F, le GERICCO.
    Med Mal Infect; 2009 Dec 15; 39(12):877-85. PubMed ID: 19346088
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May 15; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
    Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG, Pittet D, Fungal Infection Network of Switzerland.
    Clin Infect Dis; 2004 Feb 01; 38(3):311-20. PubMed ID: 14727199
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L, Davel G, Soria M, Vivot W, Córdoba S, Canteros CE, Saporiti A, EMIFN.
    Rev Argent Microbiol; 2005 Feb 01; 37(4):189-95. PubMed ID: 16502638
    [Abstract] [Full Text] [Related]

  • 8. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I.
    Cancer; 2008 Jun 01; 112(11):2493-9. PubMed ID: 18412153
    [Abstract] [Full Text] [Related]

  • 9. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C.
    Crit Care Med; 2010 Mar 01; 38(3):826-30. PubMed ID: 20042858
    [Abstract] [Full Text] [Related]

  • 10. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep 01; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 11. Candidaemia and antifungal susceptibility testing in a teaching hospital.
    Tzar MN, Shamim AS.
    Med J Malaysia; 2009 Mar 01; 64(1):61-4. PubMed ID: 19852325
    [Abstract] [Full Text] [Related]

  • 12. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B, Wang H, Wu L, Sun WJ, Li F, Liu YM.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1970-3. PubMed ID: 19062737
    [Abstract] [Full Text] [Related]

  • 13. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P, Aguado García JM, Lumbreras Bermejo C, Pérez Vela JL, Caballero Cubedo R, Sanz Sanz F, Noriega Rodríguez AR.
    Rev Clin Esp; 1997 Dec 22; 197(12):799-803. PubMed ID: 9477669
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G, FUNGEMYCA Study Group.
    J Antimicrob Chemother; 2012 May 22; 67(5):1181-7. PubMed ID: 22351683
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of candidemia at a Children's hospital, 2002 to 2006.
    Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, Saiman L.
    Pediatr Infect Dis J; 2009 Sep 22; 28(9):806-9. PubMed ID: 19636286
    [Abstract] [Full Text] [Related]

  • 16. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, Fraser VJ, Kollef MH.
    Crit Care Med; 2007 Apr 22; 35(4):1077-83. PubMed ID: 17312565
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E, Erturan Z, Susever S, Yegenoglu Y.
    APMIS; 2005 Apr 22; 113(4):278-83. PubMed ID: 15865609
    [Abstract] [Full Text] [Related]

  • 18. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
    Krcméry V, Spánik S, Grausová S, Trupl J, Krupová I, Roidová A, Sálek T, Sufliarsky J, Mardiak J.
    Neoplasma; 1998 Apr 22; 45(5):336-42. PubMed ID: 9921924
    [Abstract] [Full Text] [Related]

  • 19. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec 22; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov 22; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.